HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS Builds Health Care Reform Implementation Team With Key Hill Staffers

This article was originally published in The Tan Sheet

Executive Summary

The Senate Finance Committee's top health care staffer for health reform, Elizabeth Fowler, moves to the Department of Health and Human Services to help implement the Affordable Care Act

You may also be interested in...



People In Brief

Hash in health care reform post: Michael Hash, a former deputy administrator at what is now the Centers for Medicare and Medicaid Services, joins the Obama administration in a top-level role in health care reform. Hash's responsibilities will include coordinating reform activities between the White House Office of Health Reform and the Department of Health and Human Services. Hash was most recently a principal at Washington-based consulting firm Health Policy Alternatives. He was at the Health Care Financing Administration from 1998 to 2000 and served as deputy to Nancy-Ann DeParle, now director of the White House health reform office. From 1990 to 1995, Hash was a senior staff associate for the House Energy and Commerce Subcommittee on Health, which was chaired by Rep. Henry Waxman, D-Calif., who now chairs the full committee. Hash's work on the subcommittee included Medicare legislation and health care reform proposals

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS135468

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel